Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification

Published:2024-05 Issue: Volume:95 Page:105644
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Kira Ahmed Y.^ORCID,Abdelhamid Amir Mohamed^ORCID,Nasr Mohamed^ORCID

Publisher

Elsevier BV

Reference114 articles.

1. Global burden of liver disease: 2023 update;Devarbhavi;J. Hepatol.,2023

2. Burden of liver diseases in the world;Asrani;J. Hepatol.,2019

3. P‐Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV;Moreira;J. Clin. Pharmacol.,2023

4. Mechanisms of drug resistance in hepatocellular carcinoma;Ladd;Hepatology,2023

5. Current strategies for the treatment of hepatocellular carcinoma by modulating the tumor microenvironment via nano-delivery systems: a review;Huang;Int. J. Nanomed.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicardipine-chitosan nanoparticles alleviate thioacetamide-induced acute liver injury by targeting NFκB/NLRP3/IL-1β signaling in rats: Unraveling new roles beyond calcium channel blocking;International Immunopharmacology;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP